Page last updated: 2024-09-03

n,n-dimethylarginine and Prostatic Neoplasms

n,n-dimethylarginine has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dasari, C; Duscharla, D; Kumar, JM; Ram, NS; Reddy, KRK; Supriya, B; Surekha, MV; Ummanni, R	1
Dasari, C; Jadav, SS; Kami Reddy, KR; Kumar, JM; Natani, S; Sai Ram, N; Supriya, B; Ummanni, R; Vandavasi, S	1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Prostatic Neoplasms

Article	Year
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Angiogenesis, 2018, Volume: 21, Issue:1 Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; PC-3 Cells; Platelet Endothelial Cell Adhesion Molecule-1; Prostatic Neoplasms; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A	2018
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway. ACS combinatorial science, 2019, 04-08, Volume: 21, Issue:4 Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokines; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Nude; Molecular Docking Simulation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Prostatic Neoplasms; Pyridines; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A	2019

Article

Year

Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).

Angiogenesis, 2018, Volume: 21, Issue:1

Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; PC-3 Cells; Platelet Endothelial Cell Adhesion Molecule-1; Prostatic Neoplasms; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A

2018

Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.

ACS combinatorial science, 2019, 04-08, Volume: 21, Issue:4

Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokines; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Nude; Molecular Docking Simulation; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Prostatic Neoplasms; Pyridines; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A

2019